Inactive Instrument

Company Biomerica, Inc. OTC Bulletin Board

Equities

BMRA

US09061H3075

Medical Equipment, Supplies & Distribution

Business Summary

Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. The Company's InFoods IBS product uses a simple blood sample and is designed to identify patient-specific foods that, when removed from the diet, may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. The Company’s two subsidiaries, Biomerica de Mexico, which is used for assembly/manufacturing and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets.

Sales per Business

USD in Million2022Weight2023Weight Delta
Clinical Lab
62.0 %
3 16.2 % 3 62.0 % +8.03%
Over-the-counter
21.9 %
1 5.8 % 1 21.9 % +7.35%
Contract Manufacturing
11.4 %
0 2.4 % 1 11.4 % +32.90%
Physicians' Office
4.7 %
14 75.6 % 0 4.7 % -98.25%

Sales per region

USD in Million2022Weight2023Weight Delta
Asia
37.9 %
13 70.9 % 2 37.9 % -84.89%
Europe
33.7 %
4 23.0 % 2 33.7 % -58.56%
North America
27.5 %
1 5.3 % 1 27.5 % +47.44%
Middle East
0.7 %
0 0.4 % 0 0.7 % -44.29%
South America
0.2 %
0 0.5 % 0 0.2 % -87.78%

Managers

Managers TitleAgeSince
Chief Executive Officer 58 85-12-31
Director of Finance/CFO 43 23-02-28
Corporate Officer/Principal - 22-08-29

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 58 85-12-31
Director/Board Member 65 99-09-30
Director/Board Member 70 07-03-31
Director/Board Member 46 22-12-06
Chairman 54 23-08-24
Director/Board Member 58 20-09-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,821,646 15,592,969 ( 92.70 %) 0 92.70 %

Shareholders

NameEquities%Valuation
Granahan Investment Management, LLC
6.715 %
1,129,522 6.715 % 762 427 $
1,020,560 6.067 % 688 878 $
Wasatch Advisors, Inc.
5.667 %
953,264 5.667 % 643 453 $
Vanguard Group, Inc. (Subfiler)
3.623 %
609,365 3.623 % 411 321 $
Russell Investments Group Ltd.
1.340 %
225,435 1.340 % 152 169 $
Potomac Capital Management, Inc.
0.9969 %
167,700 0.9969 % 113 198 $
BlackRock Institutional Trust Co. NA
0.8862 %
149,081 0.8862 % 100 630 $
Geode Capital Management LLC
0.7520 %
126,506 0.7520 % 85 392 $
93,327 0.5548 % 62 996 $
71,000 0.4221 % 47 925 $
NameEquities%Valuation
Palm Management Us LLC
100.00 %
571,429 100.00 % 385 715 $

Company contact information

Biomerica, Inc.

17571 Von Karman Avenue

92614, Irvine

+

http://www.biomerica.com
address Biomerica, Inc.(BMRA)
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW